Eisler Capital (Uk) Ltd. Gilead Sciences, Inc. Put Options Transaction History

Eisler Capital (Uk) Ltd.

11 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$66.59 - $83.99 $15.9 Million - $20.1 Million	239,363 Added 103.74%	470,099 $39.4 Million
Q2 2024 Aug 13, 2024	BUY	$63.15 - $72.88 $2.2 Million - $2.53 Million	34,769 Added 17.74%	230,736 $15.8 Million
Q1 2024 May 14, 2024	BUY	$71.58 - $87.29 $5.69 Million - $6.94 Million	79,521 Added 68.29%	195,967 $14.4 Million
Q4 2023 Feb 13, 2024	SELL	$73.27 - $83.09 $989,145 - $1.12 Million	-13,500 Reduced 10.39%	116,446 $9.43 Million
Q3 2023 Nov 13, 2023	BUY	$73.94 - $80.67 $735,407 - $802,343	9,946 Added 8.29%	129,946 $9.74 Million
Q2 2023 Aug 14, 2023	SELL	$76.01 - $86.7 $4.67 Million - $5.32 Million	-61,400 Reduced 33.85%	120,000 $9.25 Million
Q1 2023 May 12, 2023	BUY	$77.31 - $88.08 $14 Million - $16 Million	181,400 New	181,400 $15.1 Million
Q2 2022 Aug 12, 2022	SELL	$57.72 - $65.01 $14.4 Million - $16.3 Million	-250,000 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $14.5 Million - $18.1 Million	250,000 New	250,000 $14.9 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $16.2 Million - $18.4 Million	-250,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $16.9 Million - $18.3 Million	250,000 New	250,000 $17.5 Million

1,926

994M

10.5M

9.75M

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $111B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

Get notified when there are updates to the investment portfolio of Eisler Capital (Uk) Ltd., based on Form 13F filings with the SEC.

Stay updated on Eisler Capital (Uk) Ltd. with notifications on news.